Onconetix | 3: Initial statement of beneficial ownership of securities-Officer FEDASZ KARINA M
Onconetix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Joseph Hernandez(0%)
Onconetix | 4: Statement of changes in beneficial ownership of securities-Director SINGH AJIT
Onconetix | 3: Initial statement of beneficial ownership of securities-Director Meier Thomas
Onconetix | 3: Initial statement of beneficial ownership of securities-Director SINGH AJIT
Onconetix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-American Financial Group, Inc.(7.7%)
Onconetix | 3: Initial statement of beneficial ownership of securities-Officer Schiess Ralph
Onconetix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Onconetix | 3: Initial statement of beneficial ownership of securities-Officer Bruhlmann Christian
Onconetix | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altos Venture AG(5.0%)
Blue Water Biotech | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer CAMPBELL NEIL J
Blue Water Biotech | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Harmon Bruce
Blue Water Biotech | SC 13D: Statement of acquisition of beneficial ownership by individuals-Cincinnati Cornerstone Investors BWV I, LLC(0%),Cincinnati Cornerstone Capital, LLC(0%)
Blue Water Biotech | 4: Statement of changes in beneficial ownership of securities-Director Jeremic Vuk
Blue Water Biotech | 4: Statement of changes in beneficial ownership of securities-Director Ramdeen Timothy R.
Blue Water Biotech | 4: Statement of changes in beneficial ownership of securities-Director Tarsh Simon
Blue Water Biotech | 4: Statement of changes in beneficial ownership of securities-Director SAPIRSTEIN JAMES
Blue Water Biotech | 4: Statement of changes in beneficial ownership of securities-CEO Hernandez Joseph
Blue Water Biotech | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Garfield Jon
Blue Water Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Erin
No Data